SCHEMBL484446

SCHEMBL484446

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5c(F)cccc5F)CC4)C3)cc21)c1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 4/20 0.43
TAS1R1 Q7RTX1 4/20 0.43
TAS1R2 Q8TE23 4/20 0.43
ALDH1A1 P00352 2/20 0.41
CYP2D6 P10635 4/20 0.40
MAPK1 P28482 1/20 0.40
ACHE P22303 1/20 0.40
SPTLC2 O15270 5/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
ACKR3 P25106 1/20 0.39
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484702 0.98 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484548 0.95 CYP2D6 (0.45) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484425 0.94 ACHE (0.46) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484832 0.93 ACHE (0.42) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL485311 0.93 CYP2D6 (0.44) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484919 0.90 CYP3A4 (0.40) CYP2D6CYP1A2CYP3A4TSHREPHX2
SCHEMBL484793 0.90 ACKR3 (0.42) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484529 0.89 CYP2D6 (0.48) TAS1R3TAS1R1ALDH1A1CYP2D6MAPK1
SCHEMBL484790 0.89 CYP2D6 (0.40) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6
SCHEMBL484741 0.89 CYP2D6 (0.42) TAS1R3TAS1R1TAS1R2ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.